Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 19.7B | 20.6B | 20.0B | 21.1B |
Cost of revenue | 17.0B | 17.7B | 14.7B | 18.1B |
Gross profit | 2.7B | 2.9B | 5.3B | 3.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.7B | 1.7B | 1.4B | 1.6B |
Operating income | 621.1M | 807.1M | 898M | 1.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 235.3M | 259.5M | 236M | 215.2M |
Other income expense | — | — | — | — |
Pretax income | 884.4M | 712.6M | 1.1B | 1.1B |
Tax provision | 251.1M | 246M | 379.8M | 360.6M |
Net income | 660.1M | 472.9M | 719.6M | 731.3M |
Basic EPS | — | 1.1 | 1.4 | 1.6 |
Diluted EPS | — | 1.1 | 1.4 | 1.6 |
Basic average shares | — | 467.7M | 466.8M | 464.8M |
Diluted average shares | — | 467.7M | 466.8M | 464.8M |
EBITDA | 1.5B | 1.4B | 1.6B | 1.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -14.4M | 22.9M | -70.7M | 21.6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |